Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00647205
What this trial is testing

Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT

Who this might be right for
HIV InfectionsTuberculosis
French National Agency for Research on AIDS and Viral Hepatitis 240
Testing effectiveness (Phase 2)Study completedNCT00128063
What this trial is testing

Succinylated Human Serum Albumin (Suc-HSA) for HIV-1 Infection

Who this might be right for
HIV Infections
International Antiviral Therapy Evaluation Center 6
Post-approval studies (Phase 4)Study completedNCT02667678
What this trial is testing

5 Years Follow-up Evaluation of Deterioration Kidney Biomarkers of HIV Patients

Who this might be right for
HIV
Centre Hospitalier Universitaire de Saint Etienne 173
Testing effectiveness (Phase 2)Active Not RecruitingNCT06006143
What this trial is testing

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2

Who this might be right for
Alcohol Use DisorderHivTobacco Use Disorder
Yale University 30
Testing effectiveness (Phase 2)WithdrawnNCT01738555
What this trial is testing

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects

Who this might be right for
Human Immunodeficiency Virus Infection
RFS Pharma, LLC
Not applicableStudy completedNCT05015855
What this trial is testing

Testing Two Models of PrEP Delivery in OBGYN Clinics

Who this might be right for
Hiv
Montefiore Medical Center 26
Testing effectiveness (Phase 2)Study completedNCT00000815
What this trial is testing

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

Who this might be right for
HIV InfectionsMeasles
National Institute of Allergy and Infectious Diseases (NIAID) 270
Not applicableStudy completedNCT02610517
What this trial is testing

ARCH Research Protocol for Provider Alcohol Pharmacotherapy Training and Assessment

Who this might be right for
HIVAlcoholism
University of Alabama at Birmingham 117
Large-scale testing (Phase 3)Study completedNCT01266902
What this trial is testing

A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1

Who this might be right for
HIV-1 Infection
Janssen R&D Ireland 482
Not applicableStudy completedNCT00002001
What this trial is testing

The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00000672
What this trial is testing

An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 660
Not applicableStudy completedNCT01824628
What this trial is testing

Comparison of the QT/QTc Interval Between an Outpatient HIV-Infected Population on Antiretroviral Therapy and Two Large HIV-Negative Cohorts

Who this might be right for
QT and Corrected QT Intervals Prolongation in HIV Positive Subjects Treated With an Antiretroviral Regimen
Centre hospitalier de l'Université de Montréal (CHUM) 160
Not applicableStudy completedNCT04633200
What this trial is testing

Mhealth for PrEP Adherence by Young Adult MSM, Phase 2

Who this might be right for
Hiv
Environment and Health Group, Inc. 108
Post-approval studies (Phase 4)UnknownNCT00759070
What this trial is testing

Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism

Who this might be right for
HIV Infections
Juan A. Arnaiz 50
Early research (Phase 1)Study completedNCT01563328
What this trial is testing

Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 32
Early research (Phase 1)WithdrawnNCT01283100
What this trial is testing

A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects.

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare
Early research (Phase 1)Study completedNCT00061100
What this trial is testing

HIV Counseling Intervention for Methadone-Maintained Patients - 2

Who this might be right for
Opioid-Related Disorders
New York State Psychiatric Institute 50
Testing effectiveness (Phase 2)Study completedNCT00001095
What this trial is testing

Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 94
Early research (Phase 1)Study completedNCT01896622
What this trial is testing

The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers

Who this might be right for
HIV
National Institutes of Health Clinical Center (CC) 40
Post-approval studies (Phase 4)Study completedNCT00540137
What this trial is testing

The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects

Who this might be right for
HIV Infections
Imperial College London 21
Next Page